Mounjaro®
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ~22.5% average body weight loss
- Significant weight reduction
- Improves blood sugar levels
- Clinically proven weight loss
Ozempic side effects in males are an important consideration for men prescribed this GLP-1 receptor agonist for type 2 diabetes management. While semaglutide is generally well-tolerated, understanding potential adverse effects—from common gastrointestinal symptoms to rare but serious complications—helps men make informed decisions and recognise when medical attention is needed. This guide explores the side effect profile of Ozempic specifically for male patients, covering management strategies, male-specific considerations including hormonal and cardiovascular factors, and guidance on when to contact your GP for safe, effective treatment.
Summary: Ozempic side effects in males primarily include gastrointestinal symptoms such as nausea, vomiting, and diarrhoea, with most effects diminishing over time as the body adjusts to treatment.
Ozempic (semaglutide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus in adults. It belongs to a class of medicines called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the action of a naturally occurring hormone that regulates blood sugar levels and appetite.
The medication is administered as a once-weekly subcutaneous injection, typically into the abdomen, thigh, or upper arm. Ozempic works through several complementary mechanisms: it stimulates insulin secretion from the pancreas when blood glucose levels are elevated, suppresses the release of glucagon (a hormone that raises blood sugar), slows gastric emptying to reduce post-meal glucose spikes, and acts on appetite centres in the brain to promote satiety and reduce food intake.
In the UK, Ozempic is approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and is available on NHS prescription for eligible patients with type 2 diabetes who meet specific criteria outlined by NICE (National Institute for Health and Care Excellence) in guideline NG28. According to NICE guidance, GLP-1 receptor agonists like Ozempic may be considered as part of triple therapy or in combination with insulin when certain HbA1c and BMI thresholds are met.
It is important to emphasise that Ozempic is only licensed for the treatment of type 2 diabetes in the UK, not for weight management. While the medication has been associated with weight loss benefits, which can be particularly beneficial for men with type 2 diabetes who are overweight or obese, the NHS England and MHRA currently discourage off-label prescribing for weight loss due to supply constraints affecting patients with diabetes. A related medication, Wegovy (also semaglutide but at a higher dose), is specifically licensed for weight management in the UK.
The most frequently reported side effects of Ozempic affect the gastrointestinal system and occur in both men and women, though individual experiences may vary. According to the UK Summary of Product Characteristics (SmPC), these effects are generally most pronounced during the initial weeks of treatment or following dose increases.
Nausea is the most common side effect, classified as 'very common' (affecting more than 1 in 10 people). This typically manifests as a persistent queasy feeling that may be worse after meals. Vomiting and diarrhoea are 'common' side effects (affecting between 1 in 10 and 1 in 100 people). Some men report constipation instead, which is also classified as 'common'. Abdominal pain or discomfort, often described as cramping or bloating, affects a significant proportion of patients during the adjustment period.
Reduced appetite is an expected pharmacological effect of Ozempic, but some men find this more pronounced than anticipated, occasionally leading to unintentional weight loss that exceeds clinical targets. Fatigue has been reported by some patients, which may relate to reduced caloric intake, changes in eating patterns, or the metabolic adjustments occurring as blood glucose stabilises.
Injection site reactions—including redness, itching, or mild swelling at the injection site—are classified as 'common'. Headaches and dizziness are also 'common' side effects, particularly in the early stages of treatment.
Importantly, hypoglycaemia (low blood sugar) is uncommon when Ozempic is used alone but becomes more likely when combined with insulin or sulfonylureas (such as gliclazide). If you're taking these medications together, your doctor may need to reduce their doses.
Most of these common side effects tend to diminish over time as the body adjusts to the medication. However, persistence or worsening of symptoms, particularly if you're unable to keep fluids down for more than 24 hours, warrants discussion with your healthcare provider.
Whilst Ozempic does not have distinctly different side effect profiles based on biological sex in clinical trials, certain considerations may be particularly relevant for men taking this medication.
Sexual function and testosterone levels have been areas of patient concern, though there is no established direct link between Ozempic and erectile dysfunction or reduced libido in clinical literature. However, significant weight loss and metabolic changes can influence hormone levels. Some research suggests that weight loss in men with obesity and type 2 diabetes may actually improve testosterone levels and sexual function over time, as excess adipose tissue can contribute to hormonal imbalances. Any concerns about sexual health should be discussed openly with your GP, as multiple factors—including diabetes itself, cardiovascular health, and psychological wellbeing—can affect sexual function.
Muscle mass preservation during weight loss is a consideration for men, who typically have greater baseline muscle mass than women. The rapid weight loss sometimes associated with Ozempic may include loss of lean muscle tissue alongside fat reduction. Men are encouraged to maintain adequate protein intake and engage in resistance training to preserve muscle mass during treatment. Protein requirements should be individualised, typically 1.0-1.2g per kilogram of ideal body weight during weight loss for most men, though those with kidney disease should follow their clinician's guidance. A referral to a dietitian may be beneficial for personalised nutritional advice.
Cardiovascular considerations are important for men, who statistically face higher rates of cardiovascular disease at younger ages than women. In the SUSTAIN-6 clinical trial, Ozempic demonstrated cardiovascular benefits, reducing the risk of major adverse cardiovascular events. However, men with pre-existing heart conditions should be monitored appropriately.
Pancreatitis risk, whilst rare, may warrant particular attention in men who consume alcohol regularly, have gallstones, or have hypertriglyceridaemia, as these are additional risk factors. Men should be counselled about moderating alcohol intake whilst on Ozempic.
Whilst most side effects of Ozempic are mild to moderate, certain serious adverse effects require immediate medical attention. Men taking this medication should be aware of warning signs that necessitate urgent assessment.
Acute pancreatitis is a rare but serious complication. Symptoms include severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting. This pain is typically more intense than the mild discomfort associated with common gastrointestinal side effects. If you experience severe abdominal pain, you should stop taking Ozempic immediately and seek urgent medical care, either through your GP, NHS 111, or A&E depending on severity. Do not restart the medication until you have been assessed by a healthcare professional.
Hypoglycaemia (low blood sugar) can occur, particularly when Ozempic is used in combination with other diabetes medications such as sulphonylureas or insulin. Warning signs include trembling, sweating, confusion, rapid heartbeat, dizziness, and extreme hunger. Severe hypoglycaemia can lead to loss of consciousness and requires emergency treatment. Men should carry glucose tablets or a sugary drink and ensure family members know how to respond to hypoglycaemic episodes. Drivers should be aware of DVLA guidance regarding diabetes and hypoglycaemia risk.
Acute kidney injury has been reported, often in the context of severe dehydration from persistent vomiting or diarrhoea. Symptoms include significantly reduced urine output, swelling in the legs or ankles, confusion, and fatigue. This requires prompt medical assessment.
Allergic reactions, though uncommon, can range from mild rash to severe anaphylaxis. Seek immediate help if you develop difficulty breathing, severe swelling of the face or throat, or widespread rash with blistering. Do not restart Ozempic after a suspected severe allergic reaction until assessed by a specialist.
Gallbladder problems, including gallstones and cholecystitis, have been associated with rapid weight loss. Symptoms include severe right upper abdominal pain, particularly after eating fatty foods, along with nausea, vomiting, and sometimes jaundice (yellowing of skin or eyes). These symptoms warrant same-day medical assessment.
Changes in vision or symptoms of diabetic retinopathy worsening should be reported promptly. Those with pre-existing diabetic retinopathy should be monitored closely, as rapid improvement in blood glucose control can occasionally exacerbate existing eye problems in the short term.
Any suspected adverse reactions to Ozempic should be reported through the MHRA Yellow Card Scheme, which helps monitor the safety of medicines.
Several evidence-based strategies can help men minimise and manage the side effects of Ozempic, improving treatment tolerability and adherence.
Gradual dose titration is the cornerstone of side effect management. According to the UK SmPC, Ozempic is typically initiated at 0.25mg weekly for four weeks, then increased to 0.5mg weekly. Further increases to 1mg or 2mg weekly should only occur at minimum 4-week intervals if tolerated and clinically indicated, with a maximum dose of 2mg weekly. This stepwise approach allows the gastrointestinal system to adapt gradually. Never increase your dose faster than prescribed.
Dietary modifications can significantly reduce gastrointestinal symptoms:
Eat smaller, more frequent meals rather than large portions
Avoid high-fat, greasy, or heavily spiced foods, which can exacerbate nausea
Eat slowly and chew thoroughly to aid digestion
Maintain adequate hydration based on your individual needs and medical conditions (those with heart failure or kidney disease should follow their clinician's advice)
Avoid lying down immediately after eating; remain upright for 2-3 hours post-meal
Limit alcohol consumption, which can worsen gastrointestinal symptoms and increase pancreatitis risk
Timing of injections should be consistent from week to week, but Ozempic can be administered at any time of day, with or without food. Some individuals find that administering Ozempic at a particular time of day helps them manage side effects, though evidence for this is limited.
Anti-nausea strategies include ginger tea, peppermint, or acupressure wristbands. If nausea is severe, your GP may prescribe anti-emetic medication for short-term use. Medications such as metoclopramide or domperidone carry their own risks (including cardiac effects with domperidone and neurological effects with metoclopramide) and should only be used under medical supervision for the shortest duration possible.
Injection technique matters: rotate injection sites, ensure the medication is at room temperature before injecting, and inject slowly. Proper technique reduces injection site reactions.
Physical activity should be maintained where possible, as regular exercise helps with blood glucose control, preserves muscle mass during weight loss, and can improve gastrointestinal motility. However, listen to your body and adjust intensity if feeling fatigued.
Adequate protein and nutrient intake is essential, particularly for men concerned about muscle preservation. Consider consultation with a dietitian for personalised nutritional guidance.
Knowing when to contact your GP or healthcare team is crucial for safe and effective use of Ozempic. Several situations warrant professional medical advice.
Before starting treatment, ensure you have discussed your complete medical history with your GP, including any history of pancreatitis, kidney disease, diabetic retinopathy, or thyroid problems. The UK SmPC notes that semaglutide caused thyroid C-cell tumours in rodent studies (though the human relevance is unknown); report any unusual neck symptoms such as a lump or persistent hoarseness while taking Ozempic.
Contact your GP promptly (within 1-2 days) if you experience:
Persistent nausea or vomiting lasting more than a few days, particularly if preventing adequate food or fluid intake
Severe or worsening gastrointestinal symptoms that don't improve with dietary modifications
Signs of dehydration: dark urine, dizziness on standing, dry mouth, reduced urination
Unexpectedly rapid weight loss (more than 1-2kg per week sustained over several weeks)
Persistent fatigue or weakness affecting daily activities
Changes in mood or mental health – while a causal link between GLP-1 receptor agonists and mood changes has not been established, seek help if you experience depression or thoughts of self-harm and report these via the Yellow Card Scheme
Difficulty managing blood glucose levels, including frequent hypoglycaemia
Routine follow-up should occur at intervals determined by your GP, typically every 3-6 months, to monitor:
HbA1c levels (glycated haemoglobin) to assess diabetes control
Kidney function (serum creatinine and eGFR)
Weight and body composition
Blood pressure and cardiovascular risk factors
Treatment goals and whether Ozempic remains appropriate
Discuss with your GP if you're planning surgery. Current UK guidance from the Centre for Perioperative Care (CPOC) and the Association of Anaesthetists often recommends continuing GLP-1 receptor agonists perioperatively with appropriate fasting and individual assessment. Follow the advice of your surgical and anaesthetic team.
Your GP can also provide referrals to specialist services such as dietitians, diabetes specialist nurses, or endocrinologists if needed. Never stop taking Ozempic abruptly without medical advice (except in cases of suspected pancreatitis or severe allergic reaction), as this may lead to deterioration in blood glucose control. Open communication with your healthcare team ensures optimal outcomes and safety throughout your treatment journey.
There is no established direct link between Ozempic and erectile dysfunction or reduced libido in clinical literature. Weight loss associated with Ozempic may actually improve testosterone levels and sexual function in men with obesity and type 2 diabetes, as excess adipose tissue can contribute to hormonal imbalances.
Most common side effects, particularly gastrointestinal symptoms like nausea and diarrhoea, tend to diminish over time as the body adjusts to the medication, typically within the first few weeks of treatment or following dose increases. Gradual dose titration helps minimise these effects.
Men should seek immediate medical care for severe persistent abdominal pain (possible pancreatitis), signs of severe hypoglycaemia (confusion, loss of consciousness), difficulty breathing or severe swelling (allergic reaction), significantly reduced urine output (kidney injury), or severe right upper abdominal pain with jaundice (gallbladder problems).
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript